The global topical scar treatment market size is estimated to reach USD 3.31 billion by 2030, registering to grow at a CAGR of 11.9% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing prevalence of burn injuries, skin-related disorders, and trauma are major factors likely to contribute to market growth. Topical products are a variety of substances, compounds, or mixtures that are designed for application on the skin, hair, or nails, with a purpose to exert their effects specifically on the applied area. They are frequently incorporated into routines for personal care, including skincare and haircare.
Moreover, the market is likely to be driven by the growing acceptance of ambulatory surgery centers and introduction of portable or mobile devices for scar treatment in both developed and developing regions. The market has seen significant technological advancements, including the introduction of laser therapies such as the Q-switched laser-based device, MedLite C6, which is specifically designed for treating acne. These laser instruments assist in the breakdown of scar tissue, thereby simplifying scar treatment procedures.
A model was established by examining the occurrence of scars across different regions and countries. It was observed that most patients preferred topical treatments for managing their scars. The usage rates of creams, gels, silicon sheets, and other products were subsequently analyzed. Furthermore, factors such as the average pricing of products, their usability, and the duration of treatment were considered to estimate the market size and allocate the segment division for each type of product.
Request a free sample copy or view report summary: Topical Scar Treatment Market Report
By product, creams dominated the market with a revenue share of 36.09% in 2024. Topical creams have specific vitamins and other skincare ingredients that help reduce a scar's appearance and is expected to positively impact the market growth.
By scar type, atrophic scars dominated the market and accounted for 37.15%. This type of scar looks like a pit and is typically caused by staphylococcus infections, acne, chickenpox, and surgery. As the demand for aesthetic appeal grows, the need for topical products to treat atrophic scars also increases.
Retail pharmacies dominated the market with a revenue share of 40.30% in 2024, driven by government support and industry consolidation, which enhances efficiency and cost-effectiveness.
In 2024, Asia-Pacific dominated the market with a revenue share of 44.7%. The region's growing healthcare infrastructure, high aesthetic consciousness among people, rapid adoption of advanced products, and a growing aging population contributes to the market's dominance
Grand View Research has segmented the global topical scar treatment market based on product, scar type, distribution channel, and region:
Topical Scar Treatment Product Outlook (Revenue, USD Million, 2018 - 2030)
Creams
Gels
Silicon Sheets
Others
Topical Scar Treatment Scar Type Outlook (Revenue, USD Million, 2018 - 2030)
Atrophic Scars
Hypertrophic & Keloid Scars
Contracture Scars
Stretch Marks
Topical Scar Treatment Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Hospital Pharmacies
Retail Pharmacies
Online
Hypermarkets/ Supermarkets
Topical Scar Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
Spain
France
Italy
Denmark
Norway
Sweden
Asia Pacific
China
India
Japan
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Topical Scar Treatment Market
Smith & Nephew PLC
Lumenis
Merz Pharmaceuticals, LLC
Sonoma Pharmaceuticals, Inc.
Cynosure
CCA Industries, Inc.
Newmedical Technology Inc.
Mölnlycke Health Care AB
Suneva Medical
Scar Heal Inc.
Pacific World Corporation
Perrigo Company plc
Enaltus LLC
"The quality of research they have done for us has been excellent..."